Publications by authors named "Emily Slotkin"

Claim this Profile
A
Antitumor Activity of Trastuzumab Deruxtecan in Pediatric Solid Tumors with Variable HER2 Expression.
Chelsey M Burke, Tamar Y Feinberg, Samantha Brosius, Umeshkumar K Bhanot, Mala Jain, Emily K Slotkin

Mol Cancer Ther· January 2026

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Single Institutional Experience Using Romiplostim to Treat Therapy-Related Thrombocytopenia in Pediatric Solid Tumor Patients.
Melanie D Degliuomini, Katherine Armstrong, Michael Curry, Audrey Mauguen, Shakeel Modak, Emily K Slotkin

Pediatr Blood Cancer· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
New Approaches to Investigate Novel Agents in Ewing Sarcoma: A Report From the Children's Oncology Group Bone Tumor Committee.
Jessica D Daley, Susan L Whiteway, Christine M Heske, Filemon S Dela Cruz, Sarah B Whittle, Emily K Slotkin

Pediatr Blood Cancer· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Spectrum and Clinical Impact of Secondary Genetic Alterations in Translocation-Associated Sarcomas.
Hsin-Yi Chang, William Tap, Emily Slotkin, Leonard Wexler, Damon Reed

JCO Precis Oncol· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
High transposable element expression in sarcomas is associated with increased immune infiltrates and improved outcomes including after immunotherapy.
Benjamin A Nacev, Martina Bradic, Hyung Jun Woo, Allison L Richards, Ciara M Kelly, Emily K Slotkin

J Immunother Cancer· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline pathogenic variants in DNA repair pathways: a key feature in a significant subset of translocation-associated sarcomas.
Carla Saoud, Josephine K Dermawan, Kanika Arora, William D Tap, Damon Reed, Emily K Slotkin

NPJ Precis Oncol· May 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
ACR-368, a CHK1/2 Kinase Inhibitor, in Patients With Relapsed or Refractory Desmoplastic Small Round Cell Tumor: Phase I/II Trial Results.
Emily K Slotkin, Audrey Mauguen, Filemon S Dela Cruz, Michael V Ortiz, Viswatej Avutu

JCO Oncol Adv· April 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Harmonization of the Upfront Osteosarcoma Treatment Paradigm for Adolescents and Young Adults.
Nicole P Daukshus, Viswatej Avutu, Emily Long Sarro, Michael D Kinnaman, Emily K Slotkin

J Adolesc Young Adult Oncol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Optimizing Ewing Sarcoma and Osteosarcoma Biopsy Acquisition: A Children's Oncology Group Bone Tumor Committee Consensus Statement.
Matthew S Dietz, Alyaa Al-Ibraheemi, Jessica L Davis, C Matthew Hawkins, Brian T Craig, Emily K Slotkin

J Natl Compr Canc Netw· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric Leukemia Roadmaps Are a Guide for Positive Metastatic Bone Sarcoma Trials.
Damon R Reed, Asmin Tulpule, Jonathan Metts, Matteo Trucco, Mark Robertson-Tessi, Emily Slotkin

J Clin Oncol· September 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chromoplexy Is a Frequent Early Clonal Event in EWSR1-Rearranged Round Cell Sarcomas That Can Be Detected Using Clinically Validated Targeted Sequencing Panels.
Josephine K Dermawan, Emily Slotkin, William D Tap, Paul Meyers, Leonard Wexler

Cancer Res· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A quality improvement initiative standardizing premedication for blood product transfusions.
Sanam Shahid, Jaclyn Rosenzweig, Alexandre Troullioud Lucas, Sheila S McThenia, Christina Fong, Emily K Slotkin

Pediatr Blood Cancer· January 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal Somatic Copy-Number Alterations Emerge and Dominate in Recurrent Osteosarcoma.
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, Brian Arnold, Max F Levine, Emily K Slotkin

Cancer Res· November 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Paediatric Strategy Forum for medicinal product development of DNA damage response pathway inhibitors in children and adolescents with cancer: ACCELERATE in collaboration with the European Medicines Agency with participation of the Food and Drug Administration.
Andrew D J Pearson, Sara Federico, Susanne A Gatz, Michael Ortiz, Giovanni Lesa, Emily K Slotkin

Eur J Cancer· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pediatric DDR inhibitor combinations: Are WEE1 there yet?
Emily K Slotkin, Michael V Ortiz, Julia L Glade Bender

Cancer· July 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot Study of Recurrent Ewing's Sarcoma Management with Vigil/Temozolomide/Irinotecan and Assessment of Circulating Tumor (ct) DNA.
Peter Anderson, Maurizio Ghisoli, Brian D Crompton, Kelly S Klega, Leonard H Wexler, Emily K Slotkin

Clin Cancer Res· May 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Irinotecan dose schedule for the treatment of Ewing sarcoma.
Emily K Slotkin, Paul A Meyers

Pediatr Blood Cancer· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Subclonal somatic copy number alterations emerge and dominate in recurrent osteosarcoma.
Michael D Kinnaman, Simone Zaccaria, Alvin Makohon-Moore, Brian Arnold, Max Levine, Emily Slotkin

bioRxiv· January 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Chemotherapy-induced thrombocytopenia in pediatric oncology: Scope of the problem and opportunities for intervention.
Melanie D Degliuomini, Katherine Armstrong, Audrey Mauguen, Emily K Slotkin, Stephen S Roberts

Pediatr Blood Cancer· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Towards a new era in the treatment of Ewing sarcoma.
Emily K Slotkin, William D Tap

Lancet· October 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective Clinical Genomic Profiling of Ewing Sarcoma: and Mutations as Recurrent Secondary Alterations of Potential Biologic and Therapeutic Relevance.
Koichi Ogura, Arielle Elkrief, Anita S Bowman, Richard P Koche, Elisa de Stanchina, Emily Slotkin

JCO Precis Oncol· August 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical sequencing of soft tissue and bone sarcomas delineates diverse genomic landscapes and potential therapeutic targets.
Benjamin A Nacev, Francisco Sanchez-Vega, Shaleigh A Smith, Cristina R Antonescu, Evan Rosenbaum, Emily K Slotkin

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Pilot study of bempegaldesleukin in combination with nivolumab in patients with metastatic sarcoma.
Sandra P D'Angelo, Allison L Richards, Anthony P Conley, Hyung Jun Woo, Mark A Dickson, Emily K Slotkin

Nat Commun· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Charting a path for prioritization of novel agents for clinical trials in osteosarcoma: A report from the Children's Oncology Group New Agents for Osteosarcoma Task Force.
Sarah B Whittle, Katharine Offer, Ryan D Roberts, Amy LeBlanc, Cheryl London, Emily K Slotkin

Pediatr Blood Cancer· September 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prospective pan-cancer germline testing using MSK-IMPACT informs clinical translation in 751 patients with pediatric solid tumors.
Elise M Fiala, Gowtham Jayakumaran, Audrey Mauguen, Jennifer A Kennedy, Nancy Bouvier, Emily K Slotkin

Nat Cancer· March 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis